Search research articles
Contact Us
Filters
Showing results (871-880 of 1,010) with videos related to
Page
of 101
Sort By:
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
Phenotype and function of IL-10 producing NK cells in individuals with malaria experience
Sarah A McNitt, Jenna K Dick, Maria Hernandez Castaneda, et al.
Carcinogenesis
|
November 9, 2018
IMP1 3' UTR shortening enhances metastatic burden in colorectal cancer
Sarah F Andres, Kathy N Williams, Jacqueline B Plesset, et al.
ESMO Open
|
June 4, 2024
Phase Ib dose-escalation trial of taselisib (GDC-0032) in combination with HER2-directed therapies in patients with advanced HER2+ breast cancer
A Grinshpun, S Ren, N Graham, et al.
Biology of Reproduction
|
October 6, 2006
Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators
A P Hess, A E Hamilton, S Talbi, et al.
Maternal and Child Health Journal
|
January 27, 2007
Health concerns of women and infants in times of natural disasters: lessons learned from Hurricane Katrina
William M Callaghan, Sonja A Rasmussen, Denise J Jamieson, et al.
Progress in Retinal and Eye Research
|
July 28, 2020
Non-specific orbital inflammation: Current understanding and unmet needs
Min Joung Lee, Stephen R Planck, Dongseok Choi, et al.
Journal of Pediatric Surgery
|
September 12, 2021
Predictors of anti-reflux procedure failure in complex esophageal atresia patients
Kyle Thompson, Benjamin Zendejas, Ali Kamran, et al.
Endocrinology
|
November 25, 2005
Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women
S Talbi, A E Hamilton, K C Vo, et al.
Cell Death and Differentiation
|
March 18, 2017
The ErbB3 receptor tyrosine kinase negatively regulates Paneth cells by PI3K-dependent suppression of Atoh1
Dana Almohazey, Yuan-Hung Lo, Claire V Vossler, et al.
ESMO Open
|
August 30, 2024
PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors
T A Yap, A D Choudhury, E Hamilton, et al.
Page
of 101
Search research articles
Search
Showing results (871-880 of 1,010) with videos related to
Sort By:
Page
of 101
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
Phenotype and function of IL-10 producing NK cells in individuals with malaria experience
Sarah A McNitt, Jenna K Dick, Maria Hernandez Castaneda, et al.
Carcinogenesis
|
November 9, 2018
IMP1 3' UTR shortening enhances metastatic burden in colorectal cancer
Sarah F Andres, Kathy N Williams, Jacqueline B Plesset, et al.
ESMO Open
|
June 4, 2024
Phase Ib dose-escalation trial of taselisib (GDC-0032) in combination with HER2-directed therapies in patients with advanced HER2+ breast cancer
A Grinshpun, S Ren, N Graham, et al.
Biology of Reproduction
|
October 6, 2006
Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators
A P Hess, A E Hamilton, S Talbi, et al.
Maternal and Child Health Journal
|
January 27, 2007
Health concerns of women and infants in times of natural disasters: lessons learned from Hurricane Katrina
William M Callaghan, Sonja A Rasmussen, Denise J Jamieson, et al.
Progress in Retinal and Eye Research
|
July 28, 2020
Non-specific orbital inflammation: Current understanding and unmet needs
Min Joung Lee, Stephen R Planck, Dongseok Choi, et al.
Journal of Pediatric Surgery
|
September 12, 2021
Predictors of anti-reflux procedure failure in complex esophageal atresia patients
Kyle Thompson, Benjamin Zendejas, Ali Kamran, et al.
Endocrinology
|
November 25, 2005
Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women
S Talbi, A E Hamilton, K C Vo, et al.
Cell Death and Differentiation
|
March 18, 2017
The ErbB3 receptor tyrosine kinase negatively regulates Paneth cells by PI3K-dependent suppression of Atoh1
Dana Almohazey, Yuan-Hung Lo, Claire V Vossler, et al.
ESMO Open
|
August 30, 2024
PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors
T A Yap, A D Choudhury, E Hamilton, et al.
Page
of 101